GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Medical & HealthCare Group Ltd (HKSE:00383) » Definitions » Return-on-Tangible-Equity

China Medical & HealthCare Group (HKSE:00383) Return-on-Tangible-Equity : 1.40% (As of Dec. 2023)


View and export this data going back to 1991. Start your Free Trial

What is China Medical & HealthCare Group Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. China Medical & HealthCare Group's annualized net income for the quarter that ended in Dec. 2023 was HK$26 Mil. China Medical & HealthCare Group's average shareholder tangible equity for the quarter that ended in Dec. 2023 was HK$1,862 Mil. Therefore, China Medical & HealthCare Group's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 was 1.40%.

The historical rank and industry rank for China Medical & HealthCare Group's Return-on-Tangible-Equity or its related term are showing as below:

HKSE:00383' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -43.67   Med: -5.02   Max: 66.91
Current: 0.64

During the past 13 years, China Medical & HealthCare Group's highest Return-on-Tangible-Equity was 66.91%. The lowest was -43.67%. And the median was -5.02%.

HKSE:00383's Return-on-Tangible-Equity is ranked worse than
68.66% of 536 companies
in the Healthcare Providers & Services industry
Industry Median: 10.215 vs HKSE:00383: 0.64

China Medical & HealthCare Group Return-on-Tangible-Equity Historical Data

The historical data trend for China Medical & HealthCare Group's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Medical & HealthCare Group Return-on-Tangible-Equity Chart

China Medical & HealthCare Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.97 -6.33 -7.95 -7.59 0.66

China Medical & HealthCare Group Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.48 -5.27 -10.00 -0.21 1.40

Competitive Comparison of China Medical & HealthCare Group's Return-on-Tangible-Equity

For the Medical Care Facilities subindustry, China Medical & HealthCare Group's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Medical & HealthCare Group's Return-on-Tangible-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Medical & HealthCare Group's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where China Medical & HealthCare Group's Return-on-Tangible-Equity falls into.



China Medical & HealthCare Group Return-on-Tangible-Equity Calculation

China Medical & HealthCare Group's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: Dec. 2022 )(A: Dec. 2023 )
=11.295/( (1554.942+1872.489 )/ 2 )
=11.295/1713.7155
=0.66 %

China Medical & HealthCare Group's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Dec. 2023 )  (Q: Jun. 2023 )(Q: Dec. 2023 )
=26.1/( (1850.757+1872.489)/ 2 )
=26.1/1861.623
=1.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2023) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


China Medical & HealthCare Group  (HKSE:00383) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


China Medical & HealthCare Group Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of China Medical & HealthCare Group's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


China Medical & HealthCare Group (HKSE:00383) Business Description

Traded in Other Exchanges
Address
333 Lockhart Road, 47th Floor, United Asia Finance Centre, Wanchai, Hong Kong, HKG
China Medical & HealthCare Group Ltd is a healthcare company operating hospitals. Its main focus is on the investment, management, and operations of healthcare and hospital businesses, eldercare businesses, trading of medical equipment and related supplies, property investment and development, securities trading and investments, provision of financial services, and strategic investment. It operates through the following business segments: Healthcare, Eldercare; Property development; Property investment; Financial services; and Securities trading and investments. The firm generates the majority of revenue from the Healthcare segment that is engaged in the operations of hospitals in the PRC.

China Medical & HealthCare Group (HKSE:00383) Headlines

No Headlines